Samir is currently completing a PhD Program in Bioinformatics at University of California, Los Angeles.

Ziad is an Assistant Professor of Medicine in Cardiology at Columbia University Medical Center and attending interventional cardiologist at the Center for Interventional Vascular Therapies.

Ayyaz is a consultant cardiac surgeon at Papworth hospital in Cambridge.

Emilie is currently a medical student at Vanderbilt and will be pursuing a career in orthopedics.

Prag is currently attending medical school at NYU in order to become a doctor and further pursue his goal of working at the intersection of medicine and technology.

Rachel is a computational scientist at the Jackson Labs for Genomic Medicine in Connecticut.

Austin recently completed his Masters in Genetic Counseling at Northwestern University. He is currently a Genetic Counselor in Hawaii.

Colleen is the lead genetic counselor in the Stanford Center for Inherited Cardiovascular Disease and a Clinical Assistant Professor in medical genetics at Stanford University. She received her masters in genetic counseling from the Johns Hopkins University and the National Human Genome Research Institute. Colleen currently serves as the co-chair of the NSGC Cardiovascular Genetics SIG. Colleen also served on an American Heart Association working committee for a recent publication on policy recommendations for genetics in cardiology. At Stanford she lectures in the medical school and genetic counseling program, sits on the psychosocial curriculum committee of the genetic counseling program, co-directs the cardiovascular genetics course, and supervises clinical rotations for trainees from the genetic counseling program and the medical genetics residency program. Her research interests include interpretation and use of genetic and genomic tests in cardiology and psychosocial impact of hereditary cardiovascular conditions.

Sebastian is currently leading 8VC’s healthcare team, investing in and building health-IT and health services businesses, alongside work in manufacturing & industrials, space, and energy.

David is a cardiologist at Kaiser Permanente.

Liz is a PhD student in Biomedical Informatics. She earned her BS in Applied Mathematics from UCLA in 2017, where she worked with Prof Grace Xiao on building bayesian networks to model regulatory elements in cancer. Previously, Liz worked with Prof Rachel Martin to develop statistical methods to detect protein aggregation, as well as Prof Pardis Sabeti to identify the optimal set of clinical variables needed to make informed medical decisions that drastically reduced the time of diagnosis for Lassa Fever. Liz is interested in developing unsupervised machine learning methods, particularly with causal inference, multiscale, multivariate problems in time series and longitudinal analysis. When she isn’t working out statistical problems or coding, Liz enjoys wilderness backpacking, skiing, and staying up-to-date about politics.

Alex finished her PhD in 2018 and moved to Los Angeles where she now works as a science communicator and video producer, using online video to get people around the world excited about genetics!

Karen is a Cloud Software Developer with the Ashley Lab group working on the Molecular Transducers of Physical Activity Consortium (MoTrPAC) Bioinformatics Center grant.

Rick Dewey is Senior Director and Head of Translational Genetics at the Regeneron Genetics Center, which utilizes large scale genomic sequencing to identify and validate drug targets.

Annika is currently starting her residency in Internal Medicine at UCLA. She has a bachelor’s degree in Human Biology and MD from Stanford University and competed in the 2012 Olympics in water polo bringing home the gold medal for Team USA. Prior to medical school, she joined the Ashley lab in 2015 working as a clinical research coordinator for the Undiagnosed Diseases Network. During medical school, she researched the genetic basis of ARVC and the genetic architecture of PKP2 with the mentorship and guidance of Dr. Parikh. She also researched yoga clinical trials for cancer survivors at MSKCC Integrative Center and health care system costs during the COVID-19 pandemic. She plans to pursue fellowship in cardiology and continue research in precision and integrative medicine.

Ayca is a postdoctoral fellow in the Ashley lab. Originally from Cupertino, she migrated south to UCLA for both her BS and PhD degrees. During her graduate work she studied the genetics of atherosclerosis, focusing on the gene expression of cell types present in the vascular wall during the initiation and progression of disease. Ayca’s projects in the Ashley lab include validation of heart failure networks and the study of cardiac metabolism using genetics and rodent disease models. Although she has has so far managed to avoid moving out of California, Ayca is proud to have been a registered voter in five different congressional districts throughout the state. Her sports team loyalties are divided accordingly.

Gherardo is working as cardiologist and Clinical Research Fellow at St. George’s University Hospital in London, UK. His main research interests at the moment are cardiomyopathies, cardiac adaptation in athletes and prevention of sudden cardiac death in the young.

Tom retired from the Ashley Lab.

Megan is beginning her 3rd year of medical school at UC San Diego and enjoys the ability to squeeze in surfing in between classes. She remains interested in a wide range of specialties, from internal medicine to orthopedic surgery and looks forward to rotations!

Noah graduated from Stanford in 2016 with a B.S. in Symbolic Systems with a concentration in artificial intelligence. He completed a honors thesis, examining the production and import of algorithmically generated artwork. Currently he is pursuing a M.S. in Biomedical Informatics to be conferred in 2017. He works as a team member for the Stanford Center for Undiagnosed Diseases, designing and improving algorithms for analysis of patient genetic data. When not working, he enjoys biking, marathon running, painting, cooking and surfing.

Becca Fuhlbrigge is a clinical research coordinator with the Ashley Lab. She grew up outside Boston and moved to Palo Alto after graduating from MIT in 2013 with a degree in Biology. After spending almost 4 years in the Fathman lab at Stanford studying type 1 diabetes, she moved to the Ashley lab to gain more clinical experience and explore new topics. Eventually, Becca hopes to go to medical school. In her free time, she enjoys hiking, cooking, and marveling at the Bay Area weather.

Rachel works at The Jackson Laboratory for Genomic Medicine as a Computational Scientist on their Genome Technologies team. Her projects are focused on creating new, innovative methods for analyzing genomic data, specially for informing medical decisions.

Megan is a genetic counselor in the Ashley lab. While originally from Philadelphia, her family moved to California when she was in elementary school and she quickly realized her love for the Bay Area. She earned a B.A. in Human Biology and M.S. in Human Genetics and Genetic Counseling at Stanford, and she is thrilled to have the opportunity to continue to work at Stanford and with such an inspiring team. Her research focuses mainly on genome sequencing and genetic variant interpretation, specifically involving its application in genomic medicine. She is also involved in disease discovery efforts that aim to identify underlying causes of Mendelian cardiac conditions through the use of next-generation sequencing technologies. Finally, she is a member of the Stanford Center for Inherited Cardiovascular Disease, where she provides genetic counseling for patients with inherited cardiac conditions and their family members. She enjoys spending time with friends and family, traveling, and competitive sailboat racing.

Chelsea is a visiting scholar from Duke University School of Medicine where she is currently obtaining her MD. She obtained her B.A. in Human Biology with a concentration in global health from Stanford University (2011) and her M.B.A. from Stanford’s Graduate School of Business (2021). During her time in business school, Chelsea took an interest in applying financial modeling to problems in health care. As a member of the Wheeler Lab, Chelsea will explore ECG abnormalities in family members of patients diagnosed with Dilated Cardiomyopathy. As a member of the Ashley Lab, she is involved in the ELITE project, which aims to identify genetic markers of physical fitness in the world’s most elite endurance athletes. She hopes to weave all of her learnings from undergraduate, medical, and business education to improve cardiovascular health amongst patients in a sustainable way for the healthcare system.

Carolyn has been completing her medical studies in Ireland while also getting to race around the world on the international elite circuit doing what she loves- Triathlon! Her aim is to specialize in Cardiology, and she hopes to qualify for the Tokyo 2020 Olympics in triathlon.

Emmi is currently finishing her pediatric residency at Helsinki University Children’s Hospital, in addition she is a postdoc at Kivelä lab, Translational Cancer Biology, Helsinki University.

Steve Hershman is Director of mHealth where he is coordinating the MyHeart Counts study, using iPads to enroll research participants into the GenePool biobank as part of the Metabolic Health Center and makes sense of exercise via omics as part of the Bioinformatics Center for Transducers of Physical Activity Consortium (MoTrPAC). Previously, he was Director of Biomedical Informatics and Principal Scientist at LifeMap Solutions where he launched the pioneering ResearchKit study Asthma Health. Steve has a BA (Biochemistry), MS (Chemistry) and MSE (Computer and Information Sciences) from the University of Pennsylvania and earned his PhD in Systems Biology from Harvard University at the lab of Vamsi Mootha investigating “Personal Genomics and Mitochondrial Disease”. Sometimes he misses the wet lab, but is usually content experimenting in the kitchen instead. At Stanford he enjoys farming on the farm.

Julian founded a digital health company, Encompass Bioscience, with co-founder Danny Park and advisors Chris Gignoux, Eimear Kenny, and Noah Zaitlen. Encompass Bioscience works to bring precision medicine to common hospital.

Hannah is a graduate student in Stanford’s Genetics PhD program, and a DOE Computational Science Graduate Fellow. She grew up in Ithaca, NY, and earned a B.S. in Biological Sciences and Biometry/Statistics from Cornell University in 2014. Her prior research topics range from plant-aphid-virus interactions to the polar bear gut microbiome. In the Ashley lab, she is focused on better understanding the biology of hypertrophic cardiomyopathy using genome-editing and bioinformatic approaches. Outside the lab, she enjoys hiking, wilderness backpacking, photography, and collecting owls.

Young is a Software Developer working with Drs. Euan Ashley and Matthew Wheeler on the Molecular Transducers of Physical Activity Consortium (MoTrPAC) project. Young’s background and expertise is in the field of software engineering, with concentration on health data science. In her free time, Young loves hiking and spending time outdoors with her family.

Jennifer is a Clinical Research Coordinator working with Dr. Matthew Wheeler on various clinical trials. Jennifer grew up in San Francisco and the East Bay. She attended the University of California, Davis and earned a degree in Biological Sciences. She is an avid snowboarder, explorer of county and national parks, and loves spending time with husband and daughter.

Vy-Van is currently a cardiologist at the University of Montreal.

Seung-Pyo is currently a visiting associate professor in the Ashley lab. After completing his MD and PhD degree at Seoul National University and his residency/fellowship in Cardiology at Seoul National University Hospital, he is currently an associate professor in the same hospital. He works primarily at the echocardiography laboratory in Korea as a specialist in cardiovascular imaging and runs numerous research on development of new imaging techniques for evaluation of various heart disease. His primary clinical interest is in managing patients with cardiomyopathies and valvular heart disease.

Born in Seoul, it is his second time studying abroad (the first being to London when he was a 7-year old boy!) and he expects to challenge things that he has not learned previously. More specifically, he expects to learn how the genetic mutations in hypertrophic cardiomyopathy is linked to the change of protein structures and how this in turn, leads to the development of cardiac dysfunction and ultimately, the clinical picture.

From a clinical perspective, he expects to learn how the clinical genetic service is run in Stanford and hopes to benchmark and implement the system when he returns to Korea. In his free time on weekends, he enjoys playing various sports with his family (cycling, skiing, soccer and what else!!!) and also, reading books. He is also getting adapted to seeing the beautiful nature of California. Seung-Pyo never has been seriously engaged in cooking at Korea. Apart from learning how mixing the genes lead to serious disease, he expects to learn how mixing the ingredients lead to serious tastes!

Roshni is currently a Research Scientist at Cytokinetics, where she is helping to develop medicines and therapies for patients with muscle diseases such as Hypertrophic Cardiomyopathy, Heart Failure, and ALS.

Mahdokht is the CEO and co-founder at Deepcell, a startup company spun out of Ashley lab. She grew up in Tehran, Iran and got her BSc in Electrical Engineering from Sharif University of Technology. She moved to the US in 2008 to continue her studies. She got introduced to the field of Bioengineering through a research scholarship at Harvard-MIT HST and earned a PhD in Bioengineering from UCLA in 2014. At Deepcell, she is developing a novel technology for isolation of rare cells.

Mikael received his PhD in Medical Science – Exercise Physiology (2011) from Karolinska Institutet in Sweden. The thesis was focused on the physiology of ultra-endurance athletes (Adventure Racers). His research interest can fit under the umbrella “scalable individualization” ranging from optimizing sport performance and understanding exercise induced cardiac to Precision Health and practical implementations of science driven knowledge and technologies. He joined the Ashley lab in 2013 and has held different positions over the years, from Visiting Assistant Professor to now being a Senior Research Consultant involved mainly in the projects “My Heart Counts” and “ELITE”. Mikael and Euan are co-founders of the exercise intelligence company svexa.

Maura finished nursing school in December 2016 and is working as a pediatric nurse at Children’s Hospital Colorado. She is completing her degree as a Pediatric Acute Care Nurse Practitioner in 2020, and, much to the Ashley Lab’s influence, will also be working towards her PhD!

Steve Pan is an instructor in the Leon H. Charney Division of Cardiology at the NYU Langone Medical Center in New York, NY in the Center for Advanced Cardiac Therapeutics, where he is an attending cardiologist taking care of advanced heart failure and left ventricular assist device patients. He also continues to do clinical research in novel heart failure therapies, inherited cardiomyopathies, and cardiac sarcoidosis.

Aleks graduated from UC Irvine in 2004, she moved back to the Bay Area in order to get more experience conducting research. Currently she is managing the Stanford Heart Failure Tissue Bank and Database. Also she is working on a variety of heart failure genetics studies including “Dramatic Response to Pharmaceutical Therapy Study” and “Variation in Gene Expression in Patients Taking Ace Inhibitors”. She acts as a genetics liaison in our Hypertrophic Cardiomyopathy Clinic-offering genetic testing and information to patients with this condition. She has a strong interest in the genetics of peripartum cardiomyopathy and is working on a study involving this population.

Marco is an Assistant Professor of Medicine (Cardiovascular Medicine) at Stanford University. He specializes in cardiac electrophysiology and more specifically inherited cardiac arrhythmias. He is a physician in the Stanford Center for Inherited Cardiovascular Disease.

James Priest MD is an assistant professor of Pediatric Cardiology at Stanford with a newly independent laboratory studying the genetic and molecular basis of congenital heart disease & long-term outcomes.

Cameron is a PhD student in the department of Genetics. He grew up on the east coast and, as soon as he was old enough to work a TV remote, began self-indoctrinating himself with a love of biology through a steady supply of Wild Discovery reruns. After a brief stint of falsely believing he wanted to study mechanical engineering, he came to his senses and enrolled in the Biochemistry and Molecular Biology program at the University of Georgia. He partook in research focusing on metabolic pathways of hyperthermophilic archaea, Lepidoptera of the Costa Rican cloud forests, and dabbled in computer science before finally taking a course on genomics. He was hooked from the moment he saw the legendary and ubiquitous NHGRI “cost per genome vs. Moore’s Law” graph for the first time.

Shortly thereafter, he landed himself a position conducting forward genetic screens on the mechanisms of chromatin remodeling and genome stability in Neurospora crassa with Zack Lewis. After two years with the Lewis lab and having likely contaminated all of his worldly possessions with N. crassa fungal spores, he enrolled in the Biosciences PhD program at Stanford and began his journey of learning how to decode clinical jargon. His current research with the Ashley lab focuses on RNA regulation of cardiac development and disease and collaborating with Stanford’s Center for Undiagnosed Diseases. He has additional research interests in long-read sequencing technology and high-throughput screening and enjoys participating in open source software development as it applies to his work.

When he’s not in lab, you may find him seeking remote wilderness areas, pretending to be athletic on single-track running trails, or learning about ecological restoration and community development projects in the Bay Area.

Xiumei is a life Science research associate in a Transplant Immunology Lab at Stanford University.

Kristin recently finished up medical school at the Hofstra Northwell School of Medicine, out in Long Island, NY. She just started her pediatric residency at Yale University in 2019. And when she’s not busy studying, you can find her running marathons or volunteering with her dog as a pet therapy team.

Pablo Cordero is currently a postdoc in Josh Stuart’s group at UCSC, where he is applying single cell genomic analyses to understand brain development.

After attending Cal Poly SLO for a degree in Psychology, Audrey stumbled upon the field of genetic counseling after watching the riveting show 90210. She was fortunate enough to interview inspiring genetic counselors throughout the country and was graciously given an opportunity to volunteer with the genetic counselors in SCICD. This led to her current role as Data Aid for the Ashley Lab. When she is not typing away at her computer or shadowing every care team professional, she is usually found studying for grad school or practicing inversions at a yoga studio.

Kinya is currently a Scientist at Bristol Myers Squibb. He was an Instructor in the Division of Cardiovascular Medicine for 5 years with the Ashley Lab. His primary research focus was on the determinants of myocardial function in the normal and diseased heart toward the goal for developing new therapies for heart failure. On a technical level, he possesses an unparalleled range of skills in molecular and cell biology, biomedical engineering, and model organisms research. He received his graduate training at the University of Tokyo, where he studied cardiac mechanics, electrophysiology, and computer simulation to investigate the mechanisms of arrhythmias induced by mechanical stimuli. After he received Ph.D., he moved to Baltimore to work in the laboratory of Dr. David Kass at Johns Hopkins University. He extended his skills and expertise toward the understanding of the pathogenesis of cardiac hypertrophy and heart failure with special focus on the influence of mechanical stimuli. After postdoctoral training, he went back to Japan working at Jichi Medical University as an assistant professor, where he developed intravital imaging technologies for cardiovascular events.

Ching is a research scientist at Gilead Sciences working on drug target discovery and validation in inflammatory diseases.

Dr. Abhinav Sharma is a cardiologist, assistant professor, and clinician-scientist in the division of cardiology at McGill University. He completed his medical school and internal medicine from McMaster University and his cardiology fellowship from the University of Alberta. He completed his PhD in epidemiology with a thesis focusing on the intersection of diabetes (T2DM) and heart failure (HF). He conducted a research fellowship at the Duke Clinical Research Institute (2015-2017). After his Advanced HF and cardiac transplant fellowship (Stanford University; 2017-2018), he continued as a visiting postgraduate scholar at Stanford University in the lab of Dr. Euan Ashley where he focused on the role of digital technologies to improve health and physical activity. He is currently a Junior 2 Fonds du Recherche Santé Quebec chercheurs-cliniciens scholar and World Heart Federation Emerging leader. He is the founder and co-director of the DECIDE-CV Cardiometabolic Clinic at the McGill University Health Centre. Furthermore, he is the heart failure fellowship program director for the McGill University Health Centre. His research work has enabled him to be a part of the Canadian Cardiovascular Society (CCS) Heart Failure Guideline committee and the CCS Cardio-Renal Guideline Committee for 2022. His research lab at McGill University (DREAM-CV) focuses on identifying leveraging novel models of care and digital health to accelerate the use and identification of therapies in patients with type 2 diabetes and heart failure.

Anna is a graduate student in the Biomedical Informatics PhD Program at Stanford University. She is interested in developing algorithms that utilize machine learning and data mining approaches to derive medically relevant conclusions from multi-layer omics data. Anna attended the Massachusetts Institute of Technology, where she double majored in Computer Science and Biological Engineering.

After graduation she pursed an M.Eng. degree at MIT Lincoln Laboratory in the Bioengineering Systems and Technologies group, where she continued to work until beginning her PhD at Stanford. During this time she developed algorithms to characterize microbiome metagenomic datasets, to predict kinship and biological ancestry from variant data, and to characterize different stages of healing from muscoskeletal injury.

Currently, Anna is developing deep learning algorithms for identifying pathogenic variants in undiagnosed diseases. She is also mining “big data” sources such as the UK Biobank and the MyHeart Counts mobile health data for meaningful associations between physical activity and health. Anna’s long term goal is to contribute to precision medicine by integrating physical activity, medical history, and genetic information to build a more complete picture of patient health.

Yael is living in Chicago where she is attending Rush University for her Masters of Science in Nursing, while working in the Neuroscience ICU at Rush Medical Center. She will be graduating in August of 2017, and is hoping to work in a critical care setting, while figuring out what to specialize in for her doctorate.

Aditya joined the Ashley Lab as a postdoctoral scholar in January 2021. He did his PhD in molecular medicine (2020) at PGIMER, India. His thesis was on knocking down the tumorigenic BCR-ABL1 transcript using CRISPR in CML. His current research interests are in developing “super AAVs” for the effective transduction of cardiomyocytes. He is also working on the functional mapping of mutations on protein 3D structures. Outside the lab, Aditya likes traveling, hiking, and going camping in the mountains.

Oretunlewa is a medical school student.

This coming year (Fall 2017), Valerie will be attending the London School of Hygiene & Tropical Medicine to begin her MSc studies in Public Health.

Shirley was the wet lab manager for the Ashley Lab and has retired to travel and spend time with family.

John is now in his final year of CT surgery training at Papworth Hospital.

Kevin is a Data Aide for the Ashley lab. He graduated from Cornell in 2014 with a BA in Physics, Chemistry and Mathematics. He spent two years working in the Stanford Physics Department on graphene and other highly correlated electron systems before a brief stint in a Material Science graduate program before realizing he wanted to transition into the medical field, which led to his current position. When he is not at his computer Kevin enjoys backpacking, reading and playing competitive Magic the Gathering.

Jessica is a graduate student in the Biomedical Informatics Ph.D. Program who is interested in clinical applications of wearable technology/mobile health for better patient management and outcomes. She received her B.S. in Cell and Molecular Biology and M.s in Bioinformatics from San Diego State University in 2011 and 2013 respectively. During her masters and subsequent, she worked for a biotech company developing noninvasive prenatal diagnostics before joining the Stanford Biomedical Informatics Ph.D. program. Outside the lab, Jessica enjoys spending time with her husband, puppy, and drinking lots of iced coffee.

Brianna works as a clinical research coordinator at the Stanford Center for Inherited Cardiovascular Disease. She is a Bay Area native with an interest in genomic medicine and bioethics, and aspirations to become a genetic counselor. On the weekends you can find her trying new foods, spending time with friends and family, and staying active.

Bob is a cardiologist at the Palo Alto VA as well as Founder of Portola Innovation.

Dana is now a medical student at the Technion American Medical School in Israel.

Daryl Waggott is a senior scientist working on emerging technologies to improve diagnostics and therapeutic aspects of precision health. He works closely with Silicon Valley companies to promote academic research through technical collaboration. Daryl is currently working on integrating genomic profiles and wearable sensor monitoring with augmented electronic medical records. These precision medical records are being used to create a learning health-care system. In addition Daryl is specifically interested in the genomics of physical activity, fitness and sport. He manages a large number of studies in this space including ELITE, MoTrPAC Bioinformatics Core, MyHeart Counts App, UK Biobank and Cooper Institute.

Clifton is a cardiologist in Oakland, CA.

Rachel Wilson is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where her work focuses on patents and innovations. Rachel has experience in molecular biology, protein engineering, genetics, sequencing, gene editing, pharmacokinetics, and toxicology.

Prior to joining the firm, Rachel was a postdoctoral fellow in Dr. Euan Ashley’s laboratory at Stanford University, where she used CRISPR-based gene editing tools to model cardiac disease in an induced pluripotent stem cell model. At Stanford, she was also a fellow in the Office of Technology Transfer, where she wrote marketing abstracts, identified licensing candidates, and evaluated technology landscapes and portfolios.

Rachel’s doctoral research in Dr. Christopher Bradfield’s laboratory at the University of Wisconsin-Madison focused on understanding the relationship between tissue physiology and environmental chemicals through the construction and examination of genetic mouse models. During graduate school, she also taught numerous courses and developed a toxicology curriculum and certificate program for a sister university in Sierra Leone.

Christopher is the Medical Director of Cardiac Electrophysiology at Palo Alto Medical Foundation, Mills Peninsula division.

Jennifer is finishing her Master’s in Biomedical Sciences in Denver, Colorado.

Sunil is a Scientist at Bristol Myers Squibb. He graduated as a postdoctoral scholar from the Ashley lab. Sunil received his Ph.D. in Molecular and Cellular Pharmacology from University of Miami Miller School of Medicine (2019), where he studied the role of phosphorylation of regulatory light chains (RLCs) in rescuing hypertrophic cardiomyopathy. In the Ashley lab, Sunil is working on troponin T common variant directed allele-specific silencing to normalize pathological cardiomyopathy in larger population. As such, he is involved in patient-derived iPSC-CM disease modeling, long read DNA/RNA sequencing, shRNA/ASO design etc. Outside of lab, Sunil enjoys Netflix thrillers, trying new cuisines and exploring the wilderness.

Kathia is a Senior Research Scientist at UCSD and her research focus is characterization of non-coding RNAs biomarkers.

Chunli received her PhD/DVM in Developmental Biology and Embryonic Engineering from the Institute of Zoology (IOZ, Beijing), Chinese Academy of Sciences (CAS), China in 2006. From 2006 to 2016, she worked as an Assistant Professor in IOZ, as a scientist in a stem cell company, and as a Research Associate in the Genetics Department/Cardiovascular Institute at Stanford University before joining the Ashley Lab.

Her major expertise is in stem cell research, including human iPSCs/ESCs derivation, iPSCs/ESCs differentiation and genome editing. She is also experienced in transgenic animal model generation, including animal cloning (somatic cell nuclear transfer), DNA injection, blastocyst injection and small animal surgery.

Her current work in the lab is in conjunction with the Stanford UDN project. She is in charge of iPSCs reprogramming and studies, as well as iPSCs related collaborated projects. She is also the lab manager for the Ashley Lab.